Celnova announces distribution agreement with Norgine
Celnova Pharma today announced that it has entered into an exclusive distribution agreement with SpePharm AG, a wholly owned subsidiary of Netherlands-based Norgine B.V., to commercialize DANTROLEN™ (dantrolene sodium) in the Argentine market. Under the new agreement, Celnova Pharma will be responsible for marketing authorizations, market access, commercialization and distribution in Argentina. “We are excited […]